Skip to main content
Equibles

Tower Research Capital LLC (TRC)

Position in CVKD — Cadrenal Therapeutics, Inc.

CIK 1533421 NEW YORK, NY
Back to CVKD Full portfolio

Position in CVKD

as of Jun 30, 2026 · filed Aug 11, 2026
Position Value
$4,281
+$2,269 QoQ
Shares Held
1,282
+226.2% QoQ
Ownership
0.036%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#5
of 18 holders
Holding Since
Mar 2023
11 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in CVKD Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Tower Research Capital LLC (TRC) holds $49,739,988 across 466 Biotechnology names. CVKD ranks #375 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ARGX
Argenx SE
 4,547 $4,218,570
2 BBIO
BridgeBio Pharma, Inc.
 38,206 $2,845,582
3 ARWR
Arrowhead Pharmaceuticals, Inc.
 34,537 $2,815,110
4 VRTX
Vertex Pharmaceuticals Inc / Ma
 4,292 $2,131,964
5 MDGL
Madrigal Pharmaceuticals, Inc.
 3,927 $2,108,602
6 AXSM
Axsome Therapeutics, Inc.
 6,437 $1,575,584
7 INSM
INSMED Inc
 10,927 $1,165,036
8 ROIV
Roivant Sciences Ltd.
 32,746 $1,158,880

All Filings in CVKD

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $4,281 1,282
2026-03-31 $2,012 393
2025-12-31 $3,606 532
2025-06-30 $1,638 136
2024-12-31 $5,332 368
2024-06-30 $4,543 9,666
2024-03-31 $5,807 9,520
2023-12-31 $6,284 8,493
2023-09-30 $5,763 8,475
2023-06-30 $407 270
2023-03-31 $1 607